Tag: PCI

NSTEMI case based discussion

Prof G Laufer (Vienna, Austria) argues in favour of CABG in multivessel disease. P Kolh (Liege, Belgium) considers the case in the context of European guidelines. A discussion follows.

Posted in Coronary Tagged with: , , , , , ,

ESC-EACTS 2010 revascularisation guidelines viewpoint & debate

D Taggart (Oxford, UK) gives his perspective on the 2010 European revascularisation guidelines, based on evidence from the literature. A discussion follows.

Posted in Coronary Tagged with: , , , , , , ,

ESC-EACTS 2010 revascularisation guidelines implementation

P Kolh (Liege, Belgium) describes the development of the 2010 European revascularisation guidelines. He emphasises the importance of the heart team and evidence-based protocols. He explores the indications for the different treatment options in stable disease, updating the guidelines with

Posted in Coronary Tagged with: , , , , , ,

FREEDOM trial

D Hildick-Smith (Brighton, UK) discusses the FREEDOM trial and other diabetic data in revascularisation, from a cardiologist’s perspective.

Posted in Coronary Tagged with: , , , , , ,

Revascularisation heart team information requirements

P Kolh (Leige, Belgium) promotes the value of the heart team and questions whom should be involved. He considers patient information, medical ethics, time and risk stratification.

Posted in Coronary Tagged with: , , , , , , ,

Effect of SYNTAX trial in Europe

P Kolh (Liege, Belgium) considers whether the SYNTAX trial has changed coronary artery disease practice in Europe. He reviews the results, examines the guidelines and emphasises the importance of risk models.

Posted in Coronary Tagged with: , , , , , , ,

Antiplatelets – PCI

D Hildick-Smith (Brighton, UK) gives an overview of the use of anti-platelet agents in patients underging PCI with stenting.

Posted in Coronary Tagged with: , , , , ,

Revascularisation heart team – surgeon’s view

D Taggart (Oxford, UK) emphasises the need for a heart team to ensure that patients receive the most appropriate guideline-driven interventions.

Posted in Coronary Tagged with: , , , , , , ,

Revascularisation heart team decision

H Luckraz (Wolverhampton, UK) assesses whether decisions made by the heart team are enacted.

Posted in Coronary Tagged with: , , , , , ,

Revascularisation heart team – cardiologist’s view

M Norell (Wolverhampton, UK) talks about the role of the revascularisation multidisclipinary heart team from a cardiology viewpoint.

Posted in Coronary Tagged with: , , , , , ,

SYNTAX trial 5 year results

D Taggart (Oxford, UK) presents the 5 year results of the SYNTAX trial, in the context of other evidence in coronary revascularisation.

Posted in Coronary Tagged with: , , , , ,

SYNTAX trial influence in the USA

JF Sabik (Cleveland, USA) considers whether the SYNTAX trial has changed practice in the USA and, if not, why not? He reviews the trial design and results before looking at registry data to inform about current patterns of coronary artery

Posted in Coronary Tagged with: , , , , , ,

Hybrid coronary revascularisation

G Angelini (Bristol, UK) explains the evolution and current status of hybrid coronary revascularisation.

Posted in Coronary Tagged with: , , , , , ,

Recent advances in interventional cardiology

N Curzen (Southampton, UK) explains the importance of physiological ischaemia and FFR in deciding optimal management for coronary disease.

Posted in Coronary Tagged with: , , , , , ,

SYNTAX 4 year results

D Taggart (Oxford, UK) presents pre-syntax evidence for CABG vs PCI, before analyzing the results of the SYNTAX trial at four years.

Posted in Coronary Tagged with: , , , , , , ,

Complete revascularisation – evidence in PCI

C Hamm (Bad Nauheim, Germany) reviews the evidence for the benefits of complete revascularisation in percutaneous coronary intervention.

Posted in Coronary Tagged with: , , , , ,

Proximal LAD disease case based discussion

M Dweck (Edinburgh, UK) presents a case of isoated proximal LAD disease. G Laufer (Vienna, Austria) argues in favour of surgery, while C Hamm (Bad Nauheim, Germany) puts forward the case for PCI. P Kolh (Liege, Belgium) considers how the

Posted in Coronary Tagged with: , , , , , , , , ,

Complete revascularisation – evidence in CABG

P Kolh (Leige, Belgium) assesses the evidence for the importance of completeness of myocardial revascularisation in coronary bypass surgery.

Posted in Coronary Tagged with: , , , , ,